Anzeige
Mehr »
Login
Mittwoch, 23.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
KI-Energiekrise: Wie dieser Small Cap die nukleare Zukunft des Silicon Valley befeuern könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CYEQ | ISIN: DK0061668225 | Ticker-Symbol: 8G8
Xetra
23.10.24
17:35 Uhr
0,690 Euro
0,000
0,00 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CS MEDICA A/S Chart 1 Jahr
5-Tage-Chart
CS MEDICA A/S 5-Tage-Chart

Aktuelle News zur CS MEDICA Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoCS MEDICA A/S Update from CEO: Progress on CANNORDIC IPO, Share Distribution & Upcoming Market Analysis1
02.10.CS MEDICA A/S Share Capital Increase Registered with the Danish Companies Registration Office3
02.10.CS MEDICA A/S Secures Sales Approval in Azerbaijan & Georgia, Valued at 1.17 mDKK3
30.09.CS MEDICA A/S: CS MEDICA's Subsidiary Signs Agreement to Target the German Market, Leveraging Expertise of Nimbus Health, a Dr. Reddy's Laboratories company.3
26.09.CS MEDICA A/S Update from CEO: Strategic Developments on CANNORDIC Planned IPO Milestones3
18.09.CS MEDICA A/S Announces Strategic Partnership with Scan MedPartners to Expand Reach into the US Market2
17.09.CS MEDICA A/S: CS MEDICA Announces Approval of CANNASEN® Pain Patch in Malaysia and Trademark Registration in Thailand3
02.09.CS MEDICA A/S: CEO Letter: Updates on BSI and Last Months' Activities7
02.09.CS MEDICA A/S: CANNORDIC India Ltd., a CS MEDICA Subsidiary, Signs Letter of Intent with the Pharmaceutical Company Zuventus Healthcare to Launch CANNASEN® in India1
21.08.CS MEDICA A/S: CS MEDICA Achieves MDR Classification, Setting New Standards in Substance-Based Medical Devices2
20.08.CS MEDICA A/S: CS MEDICA Pioneers CBD-Infused Medical Devices in Jordan with Confirmed Classification2
19.08.CS MEDICA A/S: CS MEDICA Q3 2023/2024: Growth Through Strategic Regulatory and Market Adaptations2
16.08.CS MEDICA A/S: CS MEDICA Q3 2023/2024 Results: Strong Revenue Growth of 400% Despite Production Delays1
07.08.CS MEDICA A/S: CS MEDICA's CANNORDIC Names Pharma Avanti as Preferred Partner in Brazil2
02.08.CS MEDICA A/S: CS MEDICA's Subsidiary, CANNORDIC, Signs Distributor Partnership with PHARMALINK2
01.08.CS MEDICA A/S: Press Release: CS MEDICA's View of the Evolving European CBD Market3
31.07.CS MEDICA A/S: Minutes of Extraordinary General Meeting1
26.07.CS MEDICA A/S Evaluates Pre-IPO Share Distribution for CANNORDIC Stock Spin-off2
26.07.CS MEDICA A/S: CS MEDICA Leverages Strategic Partnerships for CANNASEN® Brand Launch in APAC and MENA2
24.07.CS MEDICA A/S: CS MEDICA Receives "Intention To Grant" for European Patent Application Concerning CANNASEN® Psoriasis Gel, Reinforcing Leadership in CBD-infused Dermatological Innovations5
Seite:  Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2